Bradley Thompson

Bradley Thompson discloses dealings in Aptose Biosciences Inc. to SEC (Form 4). Between 27 June 2013 and 28 June 2017, the trades on record add up to 3 filings.

Every open-market trade on record is a sale: 1 sale worth €5,322. The rest of the record consists of 1 option exercise. Since January 2017: no purchases and 1 sale on the market.

The latest filing, published on 30 June 2017, reports an open-market sale of €5,322 in Aptose Biosciences Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.